MyMD Pharmaceuticals Statistics
Total Valuation
MYMD has a market cap or net worth of $4.25 million. The enterprise value is $2.56 million.
| Market Cap | 4.25M |
| Enterprise Value | 2.56M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, before market open.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MYMD has 2.37 million shares outstanding. The number of shares has increased by 53.79% in one year.
| Shares Outstanding | 2.37M |
| Shares Change (YoY) | +53.79% |
| Shares Change (QoQ) | +38.81% |
| Owned by Insiders (%) | 6.61% |
| Owned by Institutions (%) | 6.62% |
| Float | 2.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.43 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.62, with a Debt / Equity ratio of 0.00.
| Current Ratio | 0.62 |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -144.60% and return on invested capital (ROIC) is -173.63%.
| Return on Equity (ROE) | -144.60% |
| Return on Assets (ROA) | -88.40% |
| Return on Capital (ROIC) | -173.63% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.93M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.84% in the last 52 weeks. The beta is 2.69, so MYMD's price volatility has been higher than the market average.
| Beta (5Y) | 2.69 |
| 52-Week Price Change | -94.84% |
| 50-Day Moving Average | 2.02 |
| 200-Day Moving Average | 5.31 |
| Relative Strength Index (RSI) | 41.64 |
| Average Volume (20 Days) | 21,600 |
Short Selling Information
The latest short interest is 263,625, so 11.12% of the outstanding shares have been sold short.
| Short Interest | 263,625 |
| Short Previous Month | 283,196 |
| Short % of Shares Out | 11.12% |
| Short % of Float | 12.49% |
| Short Ratio (days to cover) | 2.71 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -17.32M |
| Pretax Income | -12.29M |
| Net Income | -17.55M |
| EBITDA | -12.29M |
| EBIT | -12.29M |
| Earnings Per Share (EPS) | -$9.57 |
Balance Sheet
The company has $1.74 million in cash and $35,981 in debt, giving a net cash position of $1.70 million or $0.72 per share.
| Cash & Cash Equivalents | 1.74M |
| Total Debt | 35,981 |
| Net Cash | 1.70M |
| Net Cash Per Share | $0.72 |
| Equity (Book Value) | 9.94M |
| Book Value Per Share | 4.19 |
| Working Capital | -1.51M |
Cash Flow
| Operating Cash Flow | -10.92M |
| Capital Expenditures | n/a |
| Free Cash Flow | -10.92M |
| FCF Per Share | -$5.10 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MYMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -53.79% |
| Shareholder Yield | -53.79% |
| Earnings Yield | -412.47% |
| FCF Yield | -256.67% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 15, 2024. It was a reverse split with a ratio of 1:30.
| Last Split Date | Feb 15, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |